![](https://images.ctfassets.net/tgf4i61m32yj/1VONHQ2GSZuNGLDonLKdDc/81066d3511cc36c45e1a98cf22528bb3/onc-og-fallback.png)
Abemaciclib Drug Information
Abemaciclib, a selective inhibitor of cyclin-dependent kinases 4 (CDK4) and 6 (CDK6), is an antineoplastic agent.[1][2][3] Brand Name: Verzenio Class: Antineoplastic Agents (10:00) Table of Contents Open All Breast Cancer Adjuvant Therapy for Early-stage …